Abstract
A 71-year-old female with a history of pulmonary embolism treated with rivaroxaban presented with acute onset shortness of breath, chest pain and palpitations. Computed tomographic pulmonary angiography (CTPA) revealed multiple bilateral pulmonary emboli. The patient was concurrently prescribed carbamazepine and was later diagnosed with recurrence of breast cancer during the admission. We discuss common drug interactions pertinent to direct oral anticoagulants (DOACs) that can increase the risk of further venous thromboembolism. This case report highlights the importance of reviewing patient medications when considering anticoagulants and the need to raise awareness of these drug interactions among clinicians when making their choice of anticoagulation. It also reinforces the current lack of evidence for use of DOACs in patients with solid organ malignancies.
| Original language | English |
|---|---|
| Pages (from-to) | 103-105 |
| Number of pages | 3 |
| Journal | Clinical Medicine, Journal of the Royal College of Physicians of London |
| Volume | 18 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Feb 2018 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Journal Article
Fingerprint
Dive into the research topics of 'Lesson of the month 2: Pulmonary embolism in a patient on rivaroxaban and concurrent carbamazepine'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver